SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 149 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $883,276 | -86.1% | 38,204 | -84.3% | 0.00% | -100.0% |
| Q2 2023 | $6,365,220 | +354.2% | 242,762 | +345.9% | 0.00% | +100.0% |
| Q1 2023 | $1,401,491 | +156.2% | 54,448 | +145.3% | 0.00% | – |
| Q2 2022 | $547,000 | -78.9% | 22,196 | -51.7% | 0.00% | -100.0% |
| Q1 2022 | $2,595,000 | +132.9% | 45,969 | +155.8% | 0.00% | – |
| Q4 2021 | $1,114,000 | -15.9% | 17,974 | -13.9% | 0.00% | – |
| Q3 2021 | $1,324,000 | -2.8% | 20,866 | -27.0% | 0.00% | -100.0% |
| Q3 2020 | $1,362,000 | +273.2% | 28,573 | +228.6% | 0.00% | – |
| Q2 2020 | $365,000 | +18.9% | 8,695 | -38.5% | 0.00% | -100.0% |
| Q3 2019 | $307,000 | – | 14,142 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 7,281,307 | $347,100,000 | 32.35% |
| BVF INC/IL | 2,053,991 | $97,914,000 | 5.33% |
| Samsara BioCapital, LLC | 398,017 | $18,973,000 | 5.29% |
| Orbimed Advisors | 7,406,307 | $353,059,000 | 4.44% |
| Consonance Capital Management LP | 602,732 | $28,732,000 | 3.50% |
| Boxer Capital, LLC | 2,075,905 | $98,958,000 | 3.42% |
| Perceptive Advisors | 3,481,148 | $165,946,000 | 2.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,234,262 | $58,837,000 | 1.43% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 974,915 | $46,474,000 | 0.95% |
| HighVista Strategies LLC | 11,477 | $547,000 | 0.40% |